-
公开(公告)号:US07468378B2
公开(公告)日:2008-12-23
申请号:US11049852
申请日:2005-02-03
申请人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
发明人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
IPC分类号: A61K31/44 , C07D275/04
CPC分类号: C07D215/48 , C07D401/12
摘要: This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1—R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.
摘要翻译: 本发明涉及式(I)的MTP / Apo-B分泌抑制剂,其中R1-R7,X1,m和n如说明书中所定义,以及包含该化合物的药物组合物,以及该化合物的使用方法和 组合物。 本发明的化合物可用于治疗肥胖症和相关疾病,病症或病症。
-
公开(公告)号:US07393958B2
公开(公告)日:2008-07-01
申请号:US11554351
申请日:2006-10-30
申请人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
发明人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
IPC分类号: C07D215/38 , A61K31/47
CPC分类号: C07D215/48 , C07D401/12
摘要: This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.
-
公开(公告)号:US07368573B2
公开(公告)日:2008-05-06
申请号:US11424488
申请日:2006-06-15
申请人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
发明人: Peter Bertinato , Michel A. Couturier , Ernest S. Hamanaka , Marcus D. Ewing , Ralph P. Robinson , Derek L. Tickner
IPC分类号: C07D215/38 , C07D215/46 , A61K31/47
CPC分类号: C07D215/48 , C07D401/12
摘要: This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.
摘要翻译: 本发明涉及式(I)的MTP / Apo-B分泌抑制剂,其中R 1〜R 7,X 1,m和n 如本说明书中所定义,以及包含该化合物的药物组合物,以及该化合物和组合物的使用方法。 本发明的化合物可用于治疗肥胖症和相关疾病,病症或病症。
-
-